The experience of diagnosis and treatment for TAFRO syndrome
Xiaolong Wu(First Affiliated Hospital of Zhengzhou University), Mingzhi Zhang(Chinese Academy of Sciences), Cunzhen Shi(First Affiliated Hospital of Zhengzhou University), Zhaoming Li(First Affiliated Hospital of Zhengzhou University), Siyu Qian(First Affiliated Hospital of Zhengzhou University), Linan Zhu(First Affiliated Hospital of Zhengzhou University), Xudong Zhang(Agricultural Genomics Institute at Shenzhen), Xiaoyan Feng(Academy of Military Medical Sciences), Xin Li(Third Affiliated Hospital of Southern Medical University), Jingjing Ge(First Affiliated Hospital of Zhengzhou University)
Cited by 8
Related Papers
PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
|Frontiers in Immunology|2017|296
Acalabrutinib (ACP-196): a selective second-generation BTK inhibitor
|Journal of Hematology & Oncology|2016|250
The Long Intergenic Noncoding RNA UFC1, a Target of MicroRNA 34a, Interacts With the mRNA Stabilizing Protein HuR to Increase Levels of β-Catenin in HCC Cells
|Gastroenterology|2014|231
miR-137 Is Frequently Down-Regulated in Gastric Cancer and Is a Negative Regulator of Cdc42
|Digestive Diseases and Sciences|2011|140
miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy
|Journal of Hematology & Oncology|2018|134